Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Stroke-Like Symptoms During Treatment: Safety First
Antithrombotics and Amyloid Therapy: Balancing Risk
Recognizing ARIA Before Symptoms Appear
Clinical Pearls in Adult Rett Syndrome Care: Supporting Long-Term Needs
Payal Kenia Gu, MD
David Lieberman MD, PhD
Clinical Pearls in Transition: Supporting Patients and Families Into Adulthood
Jennifer Martelle Tu, MD, PhD
Clinical Pearls in Recognizing Rett Syndrome: Early Signs and Diagnosis
Edward Dabrowski, MD
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Roger McIntyre, MD
Emmanuel Mignot, MD, PhD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD
Raymond Scott Turner, MD, PhD
Movements With Meaning: Reading the Pattern, Not the Label
VMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.